1. Home
  2. UA vs HAE Comparison

UA vs HAE Comparison

Compare UA & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UA
  • HAE
  • Stock Information
  • Founded
  • UA 1996
  • HAE 1971
  • Country
  • UA United States
  • HAE United States
  • Employees
  • UA N/A
  • HAE N/A
  • Industry
  • UA Apparel
  • HAE Medical/Dental Instruments
  • Sector
  • UA Consumer Discretionary
  • HAE Health Care
  • Exchange
  • UA Nasdaq
  • HAE Nasdaq
  • Market Cap
  • UA 2.8B
  • HAE 3.3B
  • IPO Year
  • UA N/A
  • HAE 1991
  • Fundamental
  • Price
  • UA $4.90
  • HAE $54.56
  • Analyst Decision
  • UA
  • HAE Buy
  • Analyst Count
  • UA 0
  • HAE 11
  • Target Price
  • UA N/A
  • HAE $86.73
  • AVG Volume (30 Days)
  • UA 7.4M
  • HAE 1.3M
  • Earning Date
  • UA 08-08-2025
  • HAE 08-07-2025
  • Dividend Yield
  • UA N/A
  • HAE N/A
  • EPS Growth
  • UA N/A
  • HAE 46.89
  • EPS
  • UA 0.23
  • HAE 3.28
  • Revenue
  • UA $5,114,713,000.00
  • HAE $1,346,046,000.00
  • Revenue This Year
  • UA N/A
  • HAE N/A
  • Revenue Next Year
  • UA $2.69
  • HAE $6.50
  • P/E Ratio
  • UA $20.98
  • HAE $16.62
  • Revenue Growth
  • UA N/A
  • HAE 0.91
  • 52 Week Low
  • UA $4.62
  • HAE $50.68
  • 52 Week High
  • UA $10.62
  • HAE $94.99
  • Technical
  • Relative Strength Index (RSI)
  • UA 32.93
  • HAE 33.12
  • Support Level
  • UA $4.90
  • HAE $53.90
  • Resistance Level
  • UA $5.13
  • HAE $56.64
  • Average True Range (ATR)
  • UA 0.18
  • HAE 1.64
  • MACD
  • UA 0.02
  • HAE 0.46
  • Stochastic Oscillator
  • UA 31.69
  • HAE 65.10

About UA Under Armour Inc. Class C

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: